treatment

The Blunt Truth

By: Katharine Cimmino, Editor-in-Chief - Marijuana, also known as “grass,” “pot,” “joint,” “weed,” “reefer,” “hashish,” and “Mary Jane,” is a…

12 years ago

Direct Association of HIV and Early Kidney Damage in Women

By: Elizabeth Kopec, PharmD Candidate c/o 2014, South University School of Pharmacy at Columbia, SC - Human immunodeficiency virus (HIV)…

12 years ago

Newly Approved: Macitentan (Opsumit®)

By: Rebecca Gilene, PharmD Candidate c/o 2014, St. Louis College of Pharmacy - The FDA approved macitentan (Opsumit®) on October…

13 years ago

Ponatinib Taken Off the Market

By: Sherine Jaison, PharmD Candidate c/o 2015 -  The leukemia chemotherapy drug ponatinib (Iclusig) has just been taken off the…

13 years ago

Still a Long Road Ahead for New Hepatitis C Treatment

By: Ramya Mathew, PharmD Candidate c/o 2015 - Vertex Pharmaceuticals, an American biotechnology company based in Cambridge, Massachusetts, has been…

13 years ago

Provider Status for Pharmacists: Call to Action or Distant Dream?

By: Samantha Schmidt, PharmD Candidate c/o 2014, Palm Beach Atlantic University - The role of pharmacists in healthcare has grown…

13 years ago

Zecuity(TM): Novel Treatment Option for Migraines

By: Arya Mathew, PharmD Candidate c/o 2014 -  About twelve percent of the U.S. population suffers from migraines, affecting adult…

13 years ago

Does Moxifloxacin Increase the Risk of Dysglycemia?

By: Nathan Trustman, PharmD Candidate c/o 2014, AMSCOP at LIU - The antibiotic class known as the fluoroquinolones is widely…

13 years ago

Nature’s Remedy… in a More Palatable Dosage Form

By: Davidta Brown, Staff Editor - Pathogenic bacteria have been enemies to human health for centuries. As recently as last…

13 years ago

New Treatment for a Deficiency in Iron-Supplement Therapies

By: Davidta Brown, Staff Editor - For the estimated 7.5 million individuals in the United States living with iron deficiency…

13 years ago

New Drug to Treat HIV-1 Hits the Market

By: Ada Seldin, Staff Editor - On August 12,2013, a new weapon against HIV-1 infection was added to the existing…

13 years ago

After 15 Years, First New Recombinant Coagulation Factor IX (Rixubis) Gains Orphan Drug Approval

By: Tamara Yunusova, Senior Staff Editor - After a lengthy fifteen-year hiatus in recombinant drug approvals, FDA-approved Recombinant Coagulation Factor…

13 years ago

Ketoconazole No More

By: Hayeon Na, Co-Copy Editor [Content-Focused] - The Food and Drug Administration (FDA) announced on July 26th that oral dosage…

13 years ago

Canagliflozin (Invokana®): New Type 2 Diabetes Drug

By: Sang Hyo Kim, Staff Editor - On March 29th 2013, the U.S Food and Drug Administration approved canagliflozin (Invokana®),…

13 years ago

Hope For Children with Acute Lymphoblastic Leukemia

By: Ada Seldin, Staff Editor - Emily Whitehead, a 7-year-old girl who fought off relapsing acute lymphoblastic leukemia (ALL), has…

13 years ago

Nattokinase use in DVT prophylaxis

Samad Tirmizi, Pharm. D. Candidate c/o 2014 - Deep vein thrombosis (DVT) is a clot formation that occurs within deep…

13 years ago

FDA’s New Warning: Acetaminophen Associated with Serious Skin Reactions

By: Andy Zhang, PharmD Candidate c/o 2015 - On August 1st, 2013, the U.S. Food and Drug Administration (FDA) released…

13 years ago

HIV Test: Making a Difference

By: Sang Hyo Kim, Staff Editor - On June 27, 2013, the Centers for Disease Control and Prevention (CDC), AIDS.gov,…

13 years ago

Novel Virus, Standard Vigilance

By: Davidta Brown, Staff Editor - When the seasons transition from winter into spring every year, healthcare providers brace for…

13 years ago

Children, Codeine, and Cytochrome P-450

By Davidta Brown, Staff Editor - For post-operative pain treatment, few drugs are as trustworthy, as tried-and-true, as codeine. Prescriptive…

13 years ago

New Findings Regarding Cardiovascular Adverse Events with ADHD Medications

By: Aleena Cherian, Co-Copy Editor [Graphics-Focused] - Attention deficit/hyperactivity disorder (ADHD) is a chronic neurological behavior characterized by persistent patterns…

13 years ago

Comparison of the New Oral Antithrombotics and Warfarin

By Omar Khalid Pharm.D. Candidate c/o 2014 - The outpour of a multitude of new oral anticoagulants in recent years…

13 years ago

Two New Agents for the Treatment of Obesity

By: Nathan Trustman, PharmD Candidate c/o 2013, AMSCOP at LIU - Obesity is defined as having a body mass index…

13 years ago

Superbug Makes Super Waves in Hospitals Across America

By: Beatrisa Popovitz, Staff Editor -  For the past decade, antibiotic resistant bacteria have been a growing concern in healthcare.…

13 years ago

Solving the HCV Enigma: Current and Future Drug Therapy for Hepatitis C

By: Tamara Yunusova, Senior Staff Editor - Approximately 3.2 million Americans have chronic hepatitis C infection.1 While acute cases are…

13 years ago

Angelina Jolie’s Double Mastectomy: What it Reveals About Today’s Genetic Testing & Road to Curing Breast Cancer

By Sang Hyo Kim, Staff Editor - Angelina Jolie, the actress recognized for her charismatic beauty, revealed to the New…

13 years ago

Faculty Spotlight: Dr. Heather Mavronicolas Forges the Path for Public Health Degree

By: Tasnima Nabi, Content-focused Co-Copy Editor - The College of Pharmacy and Health Sciences has officially launched a Master of…

13 years ago

Helping Solve the Cruel Mystery

By: Erica Dimitropoulos, Senior Staff Editor - Lupus is highly unpredictable and occurs without warning; there is no known cause…

13 years ago

FDA Approves Dimethyl Fumarate for Treatment of Relapsing Forms of Multiple Sclerosis

By: Andy Zhang, PharmD Candidate c/o 2015 - On March 28, 2013, the U.S. Food and Drug Administration announced the…

13 years ago

Noninvasive Cancer Screening—Will We Ever Get It Right?

By: Frances Sousonis, Candidate c/o 2017 - Unfortunately, cancer is a disease about which many are able to share stories.…

13 years ago

Disclosure of Clinical Research Funding: Can Ignorance be Bliss?

By: Bharat Kirthivasan, Co-Copy Editor [Content-Focused] - Most people would prefer that a research paper be mandated to disclose its…

13 years ago

Pilltalk: Innovation to Simplify Patient Counseling

By: Mitesh Patel, PharmD Candidate 2014 - $1.2 trillion- This is what the United States spends on healthcare. At 17%…

13 years ago

Alzheimer’s Disease On The Rise

By: Ada Seldin - An impending storm is threatening to stagger the health care system and the nation at large.…

13 years ago

Three-Person In Vitro Fertilization: Combating Mitochondrial Disease or Ethical Tipping Point?

By: Bharat Kirthivasan - The UK government might soon become the platform for an explosive debate on the utility and…

13 years ago

Merck Settles Lawsuits Over Vytorin

By: Tasnima Nabi, Staff Editor - Merck & Co. will pay $688 million to settle two lawsuits filed in December…

13 years ago

Increased Costs of Treatment due to the DSM-V: Implications for Pharmacy Practice

By: James W. Schurr and David Gao, PharmD Candidates 2014 - A recent Op-ed in Newsday by Allen Frances, MD…

13 years ago

New P2Y12 Antagonist on the Rise

By Nancy Rizkalla, PharmD candidate c/o 2015 -        Percutaneous coronary intervention (PCI) with subsequent stent implantation is a highly…

13 years ago

U.S. v Caronia: Misdemeanor or Constitutional Right?

By: Tamara Yunusova, Staff Editor - On December 3, 2012, the U.S. Second Circuit Court of Appeals became the first…

13 years ago

New FDA Approval: Fycompa® to Treat Seizures

By: Bhavini Shah, PharmD Candidate c/o 2013  - Fycompa® (perampanel) has received the U.S. Food and Drug Administration (FDA) approval…

13 years ago

FDA Approves New Indication for Botox (OnabotulinumtoxinA) for Urinary Incontinence

By: Bethsy Jacob, PharmD Candidate 2014 - On January 18, 2013, the U.S. Food and Drug Administration (FDA) announced a…

13 years ago

A Look at Primary Medication NonAdherence and How it can be Overcome

By:  Erica Dimitropoulos, Assistant Student Editor - Although clinical trials can affirm the efficacy and advantages of all marketed medications,…

13 years ago

Liraglutide (Victoza®) for Type 2 Diabetes Mellitus

By:  Miriam Maltz, PharmD Candidate c/o 2013, AMSCOP, Long Island University - Type 2 diabetes mellitus (T2DM) is a metabolic…

13 years ago

Emerging Pathways For Treating Hepatitis C Virus

By:  Maria Sorbera, PharmD Candidate c/o 2013, AMSCOP, LIU - Hepatitis C is the leading cause of chronic liver disease…

13 years ago

Varizig® for Chickenpox Symptoms

By: Steve Soman, Co-Editor-in-Chief - Varicella Zoster Immune Globulin (Varizig®) was approved by the FDA on December 21st of 2012.…

13 years ago

Pain Management and Palliative Care

By:  Monica Correia, PharmD Candidate c/o 2013 - This past year of advanced pharmacy rotations, has been a tremendous learning…

13 years ago

The Opioid Debate: PROP and PROMPT Battle Away

By: Tamara Yunusova - On Wednesday, July 25th a petition signed by the reform group Physicians for Responsible Opioid Prescribing…

13 years ago

FDA Approves Apixaban For Nonvalvular Atrial Fibrillation

By: Alexandra Alleva, PharmD candidate c/o 2013 - As of December 28th, Bristol-Myers Squibb and Pfizer's brand name oral anticoagulant,…

13 years ago

Breakthroughs in Gene Therapy: Pharmacogenetics and Vectors

By: Tamara Yunusova, PharmD Candidate c/o 2017 - Gene therapy? You scoff in disbelief as thoughts of designer babies, liberal…

14 years ago

Are You Prepared for RSV Season?

By: Mahdieh Danesh Yazdi, Associate Student Editor - Many of us have prepared for influenza season by receiving the flu…

14 years ago

Safety and Efficacy of Atropine for Salivary Hypersecretion

By: Elsa Thomas, PharmD Candidate c/o 2013 - Atropine is an anticholinergic used to treat various conditions, such as bradycardia,…

14 years ago